OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

OrthoPediatrics Corp. (NASDAQ:KIDS) has been given an average rating of “Moderate Buy” by the eleven ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $24.4444.

KIDS has been the subject of several recent analyst reports. Canaccord Genuity Group set a $25.00 price objective on shares of OrthoPediatrics in a research report on Friday, April 24th. BTIG Research reiterated a “buy” rating and set a $24.00 target price on shares of OrthoPediatrics in a research report on Friday, May 1st. Truist Financial set a $17.00 target price on shares of OrthoPediatrics in a research note on Friday, May 1st. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Tuesday, April 21st. Finally, TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th.

Institutional Trading of OrthoPediatrics

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KIDS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in OrthoPediatrics by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock worth $246,000 after buying an additional 645 shares during the period. Millennium Management LLC grew its stake in OrthoPediatrics by 55.3% in the first quarter. Millennium Management LLC now owns 656,578 shares of the company’s stock valued at $16,172,000 after acquiring an additional 233,873 shares during the period. Goldman Sachs Group Inc. grew its stake in OrthoPediatrics by 112.3% in the first quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock valued at $4,937,000 after acquiring an additional 106,041 shares during the period. Jane Street Group LLC bought a new stake in shares of OrthoPediatrics during the first quarter valued at approximately $389,000. Finally, American Century Companies Inc. increased its holdings in shares of OrthoPediatrics by 12.5% during the second quarter. American Century Companies Inc. now owns 34,486 shares of the company’s stock valued at $741,000 after acquiring an additional 3,828 shares in the last quarter. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Trading Down 2.8%

OrthoPediatrics stock traded down $0.56 during trading hours on Tuesday, reaching $19.89. 73,970 shares of the company’s stock were exchanged, compared to its average volume of 158,985. The firm’s 50 day simple moving average is $18.00 and its 200 day simple moving average is $17.54. OrthoPediatrics has a twelve month low of $14.42 and a twelve month high of $23.70. The company has a quick ratio of 2.37, a current ratio of 5.21 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $510.65 million, a PE ratio of -11.84 and a beta of 0.99.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Thursday, April 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.04. The company had revenue of $59.36 million for the quarter, compared to the consensus estimate of $58.28 million. OrthoPediatrics had a negative return on equity of 7.01% and a negative net margin of 16.31%. Research analysts predict that OrthoPediatrics will post -1.13 earnings per share for the current year.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.